Compare BNGO & DETX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BNGO | DETX |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Telecommunications Equipment |
| Sector | Industrials | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 14.8M |
| IPO Year | 2018 | 2022 |
| Metric | BNGO | DETX |
|---|---|---|
| Price | $1.11 | $1.29 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 171.3K | 26.9K |
| Earning Date | 11-10-2026 | 11-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.50 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,000,735.00 | N/A |
| Revenue This Year | $13.91 | N/A |
| Revenue Next Year | $33.34 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 26.26 | N/A |
| 52 Week Low | $1.00 | $1.23 |
| 52 Week High | $2.23 | $4.25 |
| Indicator | BNGO | DETX |
|---|---|---|
| Relative Strength Index (RSI) | 35.93 | 29.17 |
| Support Level | $1.08 | N/A |
| Resistance Level | $1.19 | $1.83 |
| Average True Range (ATR) | 0.06 | 0.21 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 19.97 | 17.88 |
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Liberty Defense Holdings Ltd is engaged in the development and commercialization of security detection technologies such as airports, stadiums, schools, and more. The company's Hexwave product utilizes millimeter wave technology and Advanced 3D imaging to detect concealed threats. In addition to HEXWAVE, the company has licensed High-Definition Advanced Imaging Technology (HD-AIT) for body and shoe scanning. The Company operates through three distinct segments: Corporate, HEXWAVE, and Contract. The company generates the majority of its revenue from the Contract segment. Geographically, the company generates the majority of its revenue from the United States.